PF-Atlas › Clinical Trials › NCT00000596

Diffuse Fibrotic Lung Disease

prednisone · Phase 2

Registry ID

NCT00000596

Phase

Phase 2

Status

Completed

Drug / intervention

prednisone

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Start

1978-06

About this trial

To determine the effects of cyclophosphamide compared with prednisone, dapsone, or high-dose intermittent 'pulse' therapy with methylprednisolone in patients with idiopathic pulmonary fibrosis. Also, to evaluate the use of intermittent, short-term, high-dose intravenous corticosteroids in patients with sarcoidosis. There were actually four separate clinical trials.

View NCT00000596 on ClinicalTrials.gov →

Explore related

All prednisone trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00000596 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.